INVESTORS & MEDIA

European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2018

Dec 15, 2018


Additional Information

Atara Biotherapeutics and its collaborating investigators at Memorial Sloan Kettering Cancer Center (MSK) will present tab-cel® efficacy and safety results in patients with EBV-associated leiomyosarcoma (EBV+ LMS) solid tumors.

The poster will be featured during the upcoming European Society for Medical Oncology (ESMO) Immuno-Oncology Congress held December 13-16, 2018, in Geneva, Switzerland.

View press release

View presentation